PL-3301

N/A

Report date: 2026/03/27 20:01:50
NMEFirst In Class

Base Information

Drug NamePL-3301
Drug Alias NamePL-3301
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCell membrane structures modulators
TargetsUpdating
Therapy Area/IndicationsAcute bacterial skin and skin structure infectionsCandidiasis, OralCandidiasis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPle Pharmacy (Jiangsu) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Tinovi Pharmaceutical Technology Co LtdPle Pharmacy (Jiangsu) Co Ltd
Inactive CompaniesN/A
Active IndicationsAcute bacterial skin and skin structure infectionsCandidiasis, OralCandidiasis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A